Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Amgen Announces Overall Survival Results for Vectibix in First-Line Metastatic Colorectal Cancer
Amgen, 11/06/09

Amgen announced that the Phase 3 PRIME "203" trial evaluating Vectibix (panitumumab) administered in combination with FOLFOX (an oxaliplatin–based chemotherapy) as a first–line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.

Today in Drug Trials...keeping you current

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address